Loading company…
Sebia S.A., based in France, makes clinical protein electrophoresis equipment and in vitro diagnostic reagents for disease screening.
Founded in 1967 and based in France, Sebia S.A. manufactures and distributes clinical protein electrophoresis equipment and in vitro diagnostic reagents. Its systems analyze proteins to screen and monitor conditions, mainly oncology (multiple myeloma), metabolic disorders such as diabetes, hemoglobinopathy and rare pathologies. In October 2025 Warburg Pincus acquired a minority stake from CVC Capital Partners, with closing expected in Q1 2026, subject to regulatory approvals.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in